NEW YORK (GenomeWeb) – Danaher today said its fourth quarter revenues from continuing operations grew 6 percent year over, helped by 11 percent growth in its diagnostic segment and a 6 percent improvement in its life sciences segment.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.